Grant: Canada Research Chairs
University of Toronto
$120,000.00
Stem Cell Niche Biology
EF 2024-25
Résumé
Special human cells within the body that hold the potential to grow into many different types of cells are known as stem cells. Understanding the processes that stem cells use to grow into healthy or diseased mature cells can help uncover how human diseases occur. Research to date has also shown how stem cells can be influenced by their surroundings. For example, within the blood, blood stem cells are maintained within an ecosystem provided by specialized “support cells” in the bone marrow. Although it is well known that the bone marrow microenvironment contributes to bone dysfunction and blood cancers like leukemia, the specific features, and the dynamics of the bone marrow “support cells” are not well understood. Dr. Tikhonova was the first to identify how leukemic stem cells interact with the bone marrow in a way that encourages the development of leukemia. This work also identified how to shut off these elements, which prevents cancer development. While this work highlights the unique role the microenvironment plays in cancer development, it also lays bare the need to better understand how treatments, such as chemotherapy, can manipulate the microenvironment to kill or encourage cancer development.
Dr. Tikhonova’s Canada Research Chair (CRC) program aims to address these limitations by better understanding the ecosystem in which blood stem cells are maintained. Using state-of-the-art techniques, her functional genomic studies correlated with clinical outcomes will reveal how conversations or ‘crosstalk’ between bone marrow stem cells and their environment changes during normal versus diseased states. She will extend these experiments to examine i) the specific microenvironment that supports the development of acute lymphoblastic leukemia, a cancer of the bone marrow; and ii) the unique role the immune system plays on the microenvironment and how this promotes the development of T-cell acute lymphoblastic leukemia, a particularly aggressive form of blood cancer most commonly diagnosed in children. This work will provide a global understanding of the context in which the interaction between blood stem cells and their microenvironment goes awry, which will provide critical insights that will help design effective treatments for bone marrow dysfunction and blood cancers.
Programme
Canada Research Chairs
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
CRC-2021-00408
Name nom
Tikhonova, Anastasia
Department département
Princess Margaret Cancer Centre - University Health Network
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF3010206
Field of research list names en
Hematological tumours
Field of research list names fr
Tumeurs hématologiques
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Stem Cell Niche Biology
Keywords
Hematopoiesis; Leukemia; Tumour Microenvironment; Hematopoietic Malignancies; Stem Cell Niche
Application summary
Special human cells within the body that hold the potential to grow into many different types of cells are known as stem cells. Understanding the processes that stem cells use to grow into healthy or diseased mature cells can help uncover how human diseases occur. Research to date has also shown how stem cells can be influenced by their surroundings. For example, within the blood, blood stem cells are maintained within an ecosystem provided by specialized “support cells” in the bone marrow. Although it is well known that the bone marrow microenvironment contributes to bone dysfunction and blood cancers like leukemia, the specific features, and the dynamics of the bone marrow “support cells” are not well understood. Dr. Tikhonova was the first to identify how leukemic stem cells interact with the bone marrow in a way that encourages the development of leukemia. This work also identified how to shut off these elements, which prevents cancer development. While this work highlights the unique role the microenvironment plays in cancer development, it also lays bare the need to better understand how treatments, such as chemotherapy, can manipulate the microenvironment to kill or encourage cancer development.
Dr. Tikhonova’s Canada Research Chair (CRC) program aims to address these limitations by better understanding the ecosystem in which blood stem cells are maintained. Using state-of-the-art techniques, her functional genomic studies correlated with clinical outcomes will reveal how conversations or ‘crosstalk’ between bone marrow stem cells and their environment changes during normal versus diseased states. She will extend these experiments to examine i) the specific microenvironment that supports the development of acute lymphoblastic leukemia, a cancer of the bone marrow; and ii) the unique role the immune system plays on the microenvironment and how this promotes the development of T-cell acute lymphoblastic leukemia, a particularly aggressive form of blood cancer most commonly diagnosed in children. This work will provide a global understanding of the context in which the interaction between blood stem cells and their microenvironment goes awry, which will provide critical insights that will help design effective treatments for bone marrow dysfunction and blood cancers.